299 related articles for article (PubMed ID: 23236709)
1. [Prescription of generic drugs to privately insured persons].
Wild F
Versicherungsmedizin; 2012 Dec; 64(4):190-2. PubMed ID: 23236709
[TBL] [Abstract][Full Text] [Related]
2. [Medication supply of privately insured patients in 2010].
Wild F
Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
[No Abstract] [Full Text] [Related]
3. The relationship of antidepressant prescribing concentration to treatment duration and cost.
Hodgkin D; Merrick EL; Hiatt D
J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088
[TBL] [Abstract][Full Text] [Related]
4. Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios.
Conklin MH; Culley EJ; O'Donnell J
J Manag Care Pharm; 2009; 15(1):55-61. PubMed ID: 19125550
[TBL] [Abstract][Full Text] [Related]
5. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
McCarthy M
BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
[No Abstract] [Full Text] [Related]
6. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.
Scott AB; Culley EJ; O'Donnell J
J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512
[TBL] [Abstract][Full Text] [Related]
7. The effect of introducing rebate contracts to promote generic drug substitution, on doctors' prescribing practices.
Hoffmann F; Glaeske G; Pfannkuche MS
Dtsch Arztebl Int; 2009 Nov; 106(48):783-8. PubMed ID: 20038980
[TBL] [Abstract][Full Text] [Related]
8. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
[TBL] [Abstract][Full Text] [Related]
9. [Generic and biosimilar drug substitution: a panacea?].
Daly MJ; Guignard B; Nendaz M
Rev Med Suisse; 2015 Oct; 11(490):1909-12, 1914. PubMed ID: 26665661
[TBL] [Abstract][Full Text] [Related]
10. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
[TBL] [Abstract][Full Text] [Related]
11. The effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith DG
Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
[TBL] [Abstract][Full Text] [Related]
12. [Regresses for medicine prescription: benchmark evaluations should be eliminated].
Dryden WA
MMW Fortschr Med; 2013 Nov; 155 Spec No 2():16. PubMed ID: 24734441
[No Abstract] [Full Text] [Related]
13. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
Granlund D
Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
[TBL] [Abstract][Full Text] [Related]
14. [Prescription of generic drugs in general practice. Results of a survey of general practitioners].
Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W
Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394
[TBL] [Abstract][Full Text] [Related]
15. [Can we transfer the mechanisms of the generics market to biosimilars?].
Jacke CO; Wild F
Versicherungsmedizin; 2016 Dec; 68(4):168-72. PubMed ID: 29144113
[TBL] [Abstract][Full Text] [Related]
16. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
Fritze J
Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
[No Abstract] [Full Text] [Related]
17. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
Fritze J
Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
[No Abstract] [Full Text] [Related]
18. What Is the Future of Generics in Transplantation?
van Gelder T
Transplantation; 2015 Nov; 99(11):2269-73. PubMed ID: 26050017
[TBL] [Abstract][Full Text] [Related]
19. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
20. [Biosimilars and the efficiency principle].
Münnch T
Laryngorhinootologie; 2017 Dec; 96(12):828-830. PubMed ID: 29195262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
